L'Agenzia Italiana del Farmaco rende disponibili nuove e importanti
informazioni sull'uso dei medicinali a base di interferone beta utilizzati nel trattamento della sclerosi multipla.
Particulate matter could potentially serve as a focal point for infection should any pre-existing peritonitis exist, and may lead to a fatal outcome.
Use of the affected product may cause serious adverse health consequences, including sepsis, limb loss, and death.
Undeclared sulfoaildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.
Undeclared tadalafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.
Administration of particulate matter poses a potential safety risk to patients such as a thromboembolism or a life-threatening pulmonary embolism.
Use of these products may cause bacterial infection and can lead to sepsis, a potentially life-threatening complication of an infection.
80.211.154.110
